Back
GDS Holdings Vs. CRISPR Therapeutics AG Industry Stock Comparison
Sell
48
GDS
GDS Holdings
Last Price:
$23.05
Seasonality Move:
20.95%
Sell
28
CRSP
CRISPR Therapeutics AG
Last Price:
$39.11
Seasonality Move:
20.1%
Sell
48
GDS Holdings (GDS)
is a Sell
Is GDS Holdings a Buy, Sell or Hold?
-
The current GDS Holdings [GDS] share price is $23.41. The Score for GDS is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
GDS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $39.11. The Score for CRSP is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GDS Stock Price Chart
What is GDS Holdings's stock price today?
-
The GDS Holdings share price today is $23.41Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GDS is experiencing slight buying pressure.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $39.11Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
GDS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.23 | Sell |
| Relative Strength Index (14 RSI): | 46.77 | Sell |
| Chaikin Money Flow: | -1595810 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.38 | Buy |
| Relative Strength Index (14 RSI): | 53.36 | Buy |
| Chaikin Money Flow: | 1012410 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.92 - 40.24) | Buy |
| Bollinger Bands (100): | (37.28 - 47) | Sell |
GDS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.25 | Buy |
| 20-day SMA: | 22.48 | Buy |
| 50-day SMA: | 30.4 | Sell |
| 200-day SMA: | 21.57 | Buy |
| 8-day EMA: | 21.78 | Buy |
| 20-day EMA: | 23.28 | Buy |
| 50-day EMA: | 26.16 | Sell |
| 200-day EMA: | 22.34 | Buy |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.5 | Buy |
| 20-day SMA: | 36.09 | Buy |
| 50-day SMA: | 40.73 | Sell |
| 200-day SMA: | 45.9 | Sell |
| 8-day EMA: | 38.08 | Buy |
| 20-day EMA: | 34.24 | Buy |
| 50-day EMA: | 23.43 | Buy |
| 200-day EMA: | 8.2 | Buy |
GDS Holdings Earnings Growth & GDS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and an increase next year of $0.43 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.04 per share, an increase this year of $0.12 per share, and an increase next year of $0.94 per share.
GDS Holdings Technical Analysis
| Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 10 | 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 10 | 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||